View Older Stories

Jan 20, 2026 06:54AM Structure Therapeutics (GPCR) PT Raised to $140 at Guggenheim

Jan 14, 2026 03:05PM Structure Therapeutics (GPCR) call put ratio 9.6 calls to 1 put with a focus on January and February calls as share price up 6.5%

Jan 6, 2026 07:10AM Structure Therapeutics (GPCR) Reiterated at Overweight by Cantor Fitzgerald

Jan 6, 2026 04:25AM BMO Capital on Structure Therapeutics (GPCR): 'Licensing agreement with Genentech is not the large Pharma partnership that some Structure owners have been anxiously awaiting'

Jan 5, 2026 04:11PM Structure Therapeutics subsidiary licenses patents to Genentech for $100M

Dec 22, 2025 07:10AM Structure Therapeutics (GPCR) PT Raised to $90 at H.C. Wainwright

Dec 12, 2025 04:40AM Structure Therapeutics (GPCR) PT Raised to $120 at Citizens

Dec 9, 2025 05:53AM Structure Therapeutics (GPCR) call put ratio 1.3 calls to 1 put amid sharp rally

Dec 9, 2025 05:05AM Structure Therapeutics (GPCR) PT Raised to $100 at Citi, Removes Catalyst Watch

Dec 9, 2025 04:41AM Structure Therapeutics (GPCR) PT Raised to $130 at BMO Capital

Dec 9, 2025 04:40AM Structure Therapeutics (GPCR) PT Raised to $99 at Clear Street

Dec 8, 2025 04:57PM After-hours movers: NVIDIA, Toll Brothers, and more

Dec 8, 2025 04:02PM Structure Therapeutics (GPCR) PT Raised to $90 at Stifel

Dec 8, 2025 12:14PM Jefferies on Structure Therapeutics (GPCR): 'We think the topline data is compelling and believe it reinforces a Ph3 ready profile with best-in-class weight loss'

Dec 8, 2025 08:01AM Structure Therapeutics reports weight loss data for obesity drug candidate

Dec 2, 2025 09:21AM Stifel Reiterates Buy Rating on Structure Therapeutics (GPCR)

Nov 28, 2025 06:35AM H.C. Wainwright Reiterates Buy Rating on Structure Therapeutics (GPCR)

Nov 24, 2025 04:34AM Structure Therapeutics' (GPCR) 'Aleniglipron is Well Positioned' - Citizens

Nov 20, 2025 04:07AM BMO Capital Reiterates Outperform Rating on Structure Therapeutics (GPCR)

Nov 10, 2025 08:05AM BMO Capital on Structure Therapeutics (GPCR): 'Year-End Readout Sets Key Inflection Point'

Nov 3, 2025 05:05AM Citi Opens 90-Day Upside Catalyst Watch on Structure Therapeutics (GPCR)

Oct 28, 2025 08:17AM Piper Sandler: 'Time Is Right to Own Structure Therapeutics (GPCR) Now'

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Oct 8, 2025 04:09AM Citizens Reiterates Market Outperform Rating on Terns Pharmaceuticals (TERN)

Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'

Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'

Sep 24, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Structure Therapeutics (GPCR)

Sep 17, 2025 07:03AM Cantor Fitzgerald Reiterates Overweight Rating on Structure Therapeutics (GPCR)

Sep 17, 2025 04:14AM Citizens JMP Reiterates Market Outperform Rating on Structure Therapeutics (GPCR)

Sep 8, 2025 06:53AM Cantor Fitzgerald Reiterates Overweight Rating on Structure Therapeutics (GPCR)

Aug 7, 2025 06:55AM Structure Therapeutics (GPCR) PT Lowered to $90 at Guggenheim

Aug 7, 2025 04:10AM Structure Therapeutics (GPCR) PT Lowered to $87 at Citizens JMP

Jul 30, 2025 04:51PM Clear Street Starts Structure Therapeutics (GPCR) at Buy

Jun 23, 2025 07:14AM Cantor Fitzgerald Reiterates Overweight Rating on Structure Therapeutics (GPCR)

Jun 23, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Structure Therapeutics (GPCR)

Jun 23, 2025 04:48AM Citizens JMP Reiterates Market Outperform Rating on Structure Therapeutics (GPCR)

May 2, 2025 06:53AM Citi Starts Structure Therapeutics (GPCR) at Buy

Apr 22, 2025 07:05AM H.C. Wainwright Reiterates Buy Rating on Structure Therapeutics (GPCR)

Apr 15, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Structure Therapeutics (GPCR)

Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'

Mar 18, 2025 06:52AM Cantor Fitzgerald says more options, newer targets will expand obesity market

Mar 16, 2025 10:00AM Will Pfizer step into the obesity ring? Wolfe Research answers

Mar 3, 2025 06:19AM Structure Therapeutics (GPCR) PT Lowered to $60 at Leerink Partners

Feb 28, 2025 04:13AM Structure Therapeutics (GPCR) PT Lowered to $87 at Citizens JMP

Feb 3, 2025 04:43AM JMP Securities Biotechnology Overview

Jan 7, 2025 04:07PM Stifel Starts Structure Therapeutics (GPCR) at Buy, PT $50

Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies

Dec 20, 2024 07:13AM Viking Therapeutics (VKTX), Others Gain After Novo Nordisk (NVO) Data Falls Short of Expectations

Dec 20, 2024 06:51AM H.C. Wainwright Reiterates Buy Rating on Structure Therapeutics (GPCR)

Dec 18, 2024 09:07AM Piper Sandler on Structure Therapeutics (GPCR): 'We Continue to See GPCR as One of Our Best 2025 Ideas'

View Older Stories